Clinical Evaluation of Pericardial Mesothelioma Diagnosing pericardial mesothelioma can be challenging due to its rarity and the nonspecific nature of its symptoms. The diagnosis typically involves a combination of imaging studies, laboratory tests, and histopathological examination. Clinical Evaluation Medical History: A thorough medical history, including any history of asbestos exposure, which is a major risk […]
Category: Oncology
Symptoms of Pericardial Mesothelioma Chest Pain: Patients often experience severe chest pain due to inflammation and fluid buildup around the heart. Shortness of Breath: Fluid accumulation in the pericardium (pericardial effusion) can cause breathing difficulties. Heart Palpitations: Irregular heartbeats and palpitations are common as the disease progresses. Other Symptoms: Fatigue, cough, fever, and weight loss […]
Causes of Pericardial Mesothelioma Pericardial mesothelioma is a rare and aggressive form of cancer that develops in the pericardium, the thin sac-like membrane surrounding the heart. Causes Asbestos Exposure: The primary cause of pericardial mesothelioma is exposure to asbestos fibers. These fibers can be inhaled or ingested and eventually travel to the pericardium
Lifileucel (Approval and Indications) The FDA granted accelerated approval to lifileucel for adult patients with unresectable or metastatic melanoma. Eligible patients must have been previously treated with a PD-1 blocking antibody. If they are BRAF V600 positive, they should have received a BRAF inhibitor (with or without a MEK inhibitor) as well. Lifileucel is a […]
Categories
Lifileucel (Contraindications)
Lifileucel, an autologous tumor-infiltrating lymphocyte (TIL) therapy, is used primarily for the treatment of metastatic melanoma. As a specialized form of immunotherapy, Lifileucel has specific contraindications and considerations for patient selection. Here are key contraindications and considerations: Contraindications Severe Allergies or Hypersensitivity: Patients with known hypersensitivity to any component of Lifileucel or its preparation process […]
Categories
Lifileucel (Efficacy)
Lifileucel (Efficacy) In clinical trials, lifileucel showed an objective response rate (ORR) of 31.5%, with some patients achieving complete responses. The median duration of response was not reached, indicating sustained benefits for many patients.